Growth Metrics

Cytosorbents (CTSO) EBT Margin Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -419.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 110.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -300.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 507.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -287.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 233.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 772.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -464.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 584.00
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -2,707.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,707.00
Dec 31, 2025 3,071.00
Sep 30, 2025 -551.00
Jun 30, 2025 286.00
Mar 31, 2025 5,079.00
Dec 31, 2024 -26,874.00
Sep 30, 2024 7,221.00
Jun 30, 2024 1,846.00
Mar 31, 2024 980.00
Dec 31, 2023 18,736.00
Sep 30, 2023 4,607.00
Jun 30, 2023 6,274.00
Mar 31, 2023 2,564.00
Dec 31, 2022 7,335.00
Sep 30, 2022 -8,478.00
Jun 30, 2022 -8,916.00
Mar 31, 2022 -6,384.00
Dec 31, 2021 -7,805.00
Sep 30, 2021 -5,767.00
Jun 30, 2021 -963.00
Mar 31, 2021 33.00
Dec 31, 2020 5,276.00
Sep 30, 2020 10,500.00
Jun 30, 2020 2,765.00
Mar 31, 2020 5,442.00
Dec 31, 2019 3,119.00
Sep 30, 2019 -6,064.00
Jun 30, 2019 4,423.00
Mar 31, 2019 -3,352.00
Dec 31, 2018 -1,675.00
Sep 30, 2018 140.00
Jun 30, 2018 -5,250.00
Mar 31, 2018 -1,158.00
Dec 31, 2017 8,714.00
Sep 30, 2017 3,701.00
Jun 30, 2017 8,659.00
Mar 31, 2017 5,247.00
Dec 31, 2016 3,907.00
Sep 30, 2016 12,119.00
Jun 30, 2016 -28,403.00
Mar 31, 2016 55,090.00
Dec 31, 2015 40,734.00
Sep 30, 2015 -8,302.00
Jun 30, 2015 32,970.00
Mar 31, 2015 -56,054.00
Dec 31, 2014 -55,696.00
Sep 30, 2014 1,357.00
Jun 30, 2014 92,483.00
Mar 31, 2014 83,322.00
Dec 31, 2013 99,772.00
Sep 30, 2013 462,380.00
Jun 30, 2013 98,889.00
Mar 31, 2013 191,533.00
Dec 31, 2012 226,110.00